|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.08 HKD | -0.92% |
|
-6.90% | -29.41% |
| Apr. 19 | Lee’s Pharmaceutical's 2023 Profit Slumps 67% | MT |
| Mar. 26 | Lee's Pharmaceutical Holdings Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 17 June 2024 | CI |
Lee's Pharmaceutical Holdings Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was HKD 512.31 million compared to HKD 649.17 million a year ago. Net income was HKD 16.12 million compared to HKD 28.46 million a year ago.
Basic earnings per share from continuing operations was HKD 0.0274 compared to HKD 0.0483 a year ago. Diluted earnings per share from continuing operations was HKD 0.0274 compared to HKD 0.0483 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.41% | 81.24M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
LEE'S PHARMACEUTICAL HOLDINGS LIMITED 
